title: Review of treatment options for nonalcoholic fatty liver disease.
abstract: Although the future of NAFLD and NASH treatment has many promising agents, clinicians are currently faced with limited options with an emphasis on lifestyle modification. Figs. 1 and 2 summarize current practices for the diagnosis and treatment of NAFLD with the understanding that each patient's treatment must be customized to their comorbidities, exercise tolerance, and willingness to comply with therapy.
authors.affiliation: Department of Medicine, Walter Reed National Military Medical Center, 8901 Wisconsin Avenue, Bethesda, MD 20889-5600, USA.
authors.forename: Richele L
authors.initials: RL
authors.lastname: Corrado
authors.forename: Dawn M
authors.initials: DM
authors.lastname: Torres
authors.forename: Stephen A
authors.initials: SA
authors.lastname: Harrison
mesh_terms: D050110:Bariatric Surgery; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy / Q000379:methods; D015897:Comorbidity; D003920:Diabetes Mellitus / Q000453:epidemiology*; D004035:Diet Therapy; D019468:Disease Management; D018450:Disease Progression; D005081:Exercise Therapy; D005234:Fatty Liver / Q000175:diagnosis / Q000453:epidemiology / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008019:Life Style; D008111:Liver Function Tests; D065626:Non-alcoholic Fatty Liver Disease; D009765:Obesity / Q000453:epidemiology*; D015995:Prevalence; D012307:Risk Factors
chemical_list: D000960:Hypolipidemic Agents
keywords: Diagnosis; Epidemiology; NAFLD; NASH; Treatment